Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC
Phase 1
- Conditions
- Melanoma Stage IVUnresectable MelanomaNSCLC Stage IV
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Ella Therapeutics Ltd
- Target Recruit Count
- 42
- Registration Number
- NCT04521075
- Locations
- 🇮🇱
Sheba Medical Center, Ramat Gan, Israel
News
No news found